Abstract The International Agency for Research on Cancer and the National Cancer Institute
have acknowledged human papillomavirus (HPV)‐16 as an independent risk factor for …

STUDY OBJECTIVE: The current study presents findings from a qualitative examination of
free text comments from a national survey of US physicians on human papillomavirus …

The human papillomavirus (HPV) vaccine prevents cancer and is highly effective; however,
the uptake has been low in the United States of America (USA) and among the most …

Human papillomavirus (HPV) causes nearly all cervical cancer. Only half of females and
less than half of males receive the recommended HPV vaccine dose. This study explores …

Objectives: To assess factors associated with HPV vaccine-related awareness and
knowledge among caregivers of adolescents from five ethnic community groups in Utah …

Abstract Background: Over 16,000 women are diagnosed with a human papillomavirus
(HPV)-associated gynecologic cancer every year. Because most of these cancers are …

Abstract Information is provided for clinicians who treat adolescents and adult women to use
when counseling patients about human papillomavirus (HPV) vaccine. A literature search …

Objective Physicians are the sole prescribers of the human papillomavirus (HPV) vaccine for
adults in Canada. This survey of Canadian physicians aimed to explore knowledge, barriers …

Improving human papillomavirus (HPV) vaccination is a national priority but uptake declined
following the coronavirus pandemic. A strong predictor of HPV vaccination in the USA is a …

To examine differences in knowledge, attitudes, and related practices among adopters and
nonadopters of the human papillomavirus (HPV) vaccine, the researchers conducted 83 in …